November 2023

Insulin icodec, a once-weekly basal injection to treat type 1 diabetes, has the potential to be as effective in managing the condition as daily basal insulin treatments, according to research from the University of Surrey. The results of the year-long phase 3 clinical trial could revolutionise the future of diabetes care and help millions of people better manage their condition.

A mechanism that led some patients to experience cases of deadly clotting following some types of Covid-19 vaccination has been identified in new research.

In a recent paper published in Blood, scientists from the University of Birmingham funded by the National Institute for Health and Care Research and the British Heart Foundation have been able to identify how deadly blood clots, in the disease known as Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT), occur.

Zydus Lifesciences Ltd. with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

After the success of the previous six editions, Eminence Business Media is delighted to announce the 7th Annual Pharma Project & Portfolio Management 2024. It is an eagerly anticipated event for the pharma industry most demanding i.e., portfolio teams and results-driven teams i.e., project teams. This event serves as a comprehensive platform for project and portfolio professionals to navigate their day-to-day challenges and envision the future of the pharma sector.

Intercharm Moscow 2023 was held from 25th - 28th October 2023 at Crocus Expo, Moscow, Russian Federation. This was 29th International exhibition for perfumery and cosmetics industry.